
Home » BMS Submits New Treatment Regimen in Japan for Patients with Chronic Hepatitis C
BMS Submits New Treatment Regimen in Japan for Patients with Chronic Hepatitis C
November 5, 2013
Bristol-Myers Squibb announced the submission of a new drug application to Japan’s Pharmaceutical and Medical Devices Agency seeking the world’s first interferon-free and ribavirin-free treatment regimen for patients with chronic hepatitis C.
Bristol-Meyers Squibb
Bristol-Meyers Squibb
Upcoming Events
-
10Mar
-
16Mar
-
18Mar
-
23Mar
-
30Mar
-
06Apr